Back to search

Italy· 043088020

FLUGENIX*sosp nebul 20 contenitori monod 2 ml 500 mcg/2 ml

A corticosteroids, potent (group iii) product containing fluticasone, registered in Italy by GENETIC SpA, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC D07AC

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedFLUGENIX*sosp nebul 20 contenitori mo…ATCD07ACREGISTER NO.043088020PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Fluticasone is registered in 2 of 19 countries.

Countries holding a registration under ATC D07AC (corticosteroids, potent (group iii)), each read from that country’s own register.

  • This record: Italy
  • 2 of them publish a price we can compare per daily dose

Fluticasone · ATC D07AC

2 / 19 countries

  • Italyprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Fluticasone
Manufacturer
GENETIC SpA
Country
Italy (IT)
ATC code
D07AC
ATC class
Corticosteroids, potent (group III)
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    043088020
    FLUGENIX*sosp nebul 20 contenitori monod 2 ml 500 mcg/2 ml
    EUR 11.71

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e857cffa-a3d1-4666-a21a-530162c9e93e
GET /v1/drugs/e857cffa-a3d1-4666-a21a-530162c9e93e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 11.71,
  "source": "aifa",
  "currency": "EUR",
  "strength": "FLUTICASONE 500MCG 20 UNITA' USO RESPIRATORIO",
  "substance": "Fluticasone",
  "equivalence_group": "JUH",
  "transparency_flag": null
}

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.